Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Anti Obesity Drugs Market Report 2016

  • QYR799760
  • 119 Pages
  • December 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies sales (consumption) of Anti Obesity Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer

Merck

Roche

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Novo Nordisk

Eisai

Norgine

Arena Pharmaceuticals

Orexigen Therapeutics

Vivus

Alizyme

Rhythm Pharmaceuticals

Shionogi

Zafgan

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Anti Obesity Drugs in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Europe Anti Obesity Drugs Market Report 2016

1 Anti Obesity Drugs Overview

1.1 Product Overview and Scope of Anti Obesity Drugs

1.2 Classification of Anti Obesity Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Anti Obesity Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Anti Obesity Drugs Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Anti Obesity Drugs (2011-2021)

1.5.1 Europe Anti Obesity Drugs Sales and Growth Rate (2011-2021)

1.5.2 Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

2 Europe Anti Obesity Drugs by Manufacturers, Type and Application

2.1 Europe Anti Obesity Drugs Market Competition by Manufacturers

2.1.1 Europe Anti Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Anti Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Anti Obesity Drugs (Volume and Value) by Type

2.2.1 Europe Anti Obesity Drugs Sales and Market Share by Type (2011-2016)

2.2.2 Europe Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)

2.3 Europe Anti Obesity Drugs (Volume and Value) by Countries

2.3.1 Europe Anti Obesity Drugs Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Anti Obesity Drugs Revenue and Market Share by Countries (2011-2016)

2.4 Europe Anti Obesity Drugs (Volume) by Application

3 Germany Anti Obesity Drugs (Volume, Value and Sales Price)

3.1 Germany Anti Obesity Drugs Sales and Value (2011-2016)

3.1.1 Germany Anti Obesity Drugs Sales and Growth Rate (2011-2016)

3.1.2 Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

3.1.3 Germany Anti Obesity Drugs Sales Price Trend (2011-2016)

3.2 Germany Anti Obesity Drugs Sales and Market Share by Manufacturers

3.3 Germany Anti Obesity Drugs Sales and Market Share by Type

3.4 Germany Anti Obesity Drugs Sales and Market Share by Application

4 France Anti Obesity Drugs (Volume, Value and Sales Price)

4.1 France Anti Obesity Drugs Sales and Value (2011-2016)

4.1.1 France Anti Obesity Drugs Sales and Growth Rate (2011-2016)

4.1.2 France Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

4.1.4 France Anti Obesity Drugs Sales Price Trend (2011-2016)

4.2 France Anti Obesity Drugs Sales and Market Share by Manufacturers

4.3 France Anti Obesity Drugs Sales and Market Share by Type

4.4 France Anti Obesity Drugs Sales and Market Share by Application

5 UK Anti Obesity Drugs (Volume, Value and Sales Price)

5.1 UK Anti Obesity Drugs Sales and Value (2011-2016)

5.1.1 UK Anti Obesity Drugs Sales and Growth Rate (2011-2016)

5.1.2 UK Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

5.1.5 UK Anti Obesity Drugs Sales Price Trend (2011-2016)

5.2 UK Anti Obesity Drugs Sales and Market Share by Manufacturers

5.3 UK Anti Obesity Drugs Sales and Market Share by Type

5.4 UK Anti Obesity Drugs Sales and Market Share by Application

6 Russia Anti Obesity Drugs (Volume, Value and Sales Price)

6.1 Russia Anti Obesity Drugs Sales and Value (2011-2016)

6.1.1 Russia Anti Obesity Drugs Sales and Growth Rate (2011-2016)

6.1.2 Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

6.1.6 Russia Anti Obesity Drugs Sales Price Trend (2011-2016)

6.2 Russia Anti Obesity Drugs Sales and Market Share by Manufacturers

6.3 Russia Anti Obesity Drugs Sales and Market Share by Type

6.4 Russia Anti Obesity Drugs Sales and Market Share by Application

7 Italy Anti Obesity Drugs (Volume, Value and Sales Price)

7.1 Italy Anti Obesity Drugs Sales and Value (2011-2016)

7.1.1 Italy Anti Obesity Drugs Sales and Growth Rate (2011-2016)

7.1.2 Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

7.1.7 Italy Anti Obesity Drugs Sales Price Trend (2011-2016)

7.2 Italy Anti Obesity Drugs Sales and Market Share by Manufacturers

7.3 Italy Anti Obesity Drugs Sales and Market Share by Type

7.4 Italy Anti Obesity Drugs Sales and Market Share by Application

8 Spain Anti Obesity Drugs (Volume, Value and Sales Price)

8.1 Spain Anti Obesity Drugs Sales and Value (2011-2016)

8.1.1 Spain Anti Obesity Drugs Sales and Growth Rate (2011-2016)

8.1.2 Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

8.1.8 Spain Anti Obesity Drugs Sales Price Trend (2011-2016)

8.2 Spain Anti Obesity Drugs Sales and Market Share by Manufacturers

8.3 Spain Anti Obesity Drugs Sales and Market Share by Type

8.4 Spain Anti Obesity Drugs Sales and Market Share by Application

9 Benelux Anti Obesity Drugs (Volume, Value and Sales Price)

9.1 Benelux Anti Obesity Drugs Sales and Value (2011-2016)

9.1.1 Benelux Anti Obesity Drugs Sales and Growth Rate (2011-2016)

9.1.2 Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Anti Obesity Drugs Sales Price Trend (2011-2016)

9.2 Benelux Anti Obesity Drugs Sales and Market Share by Manufacturers

9.3 Benelux Anti Obesity Drugs Sales and Market Share by Type

9.4 Benelux Anti Obesity Drugs Sales and Market Share by Application

10 Europe Anti Obesity Drugs Manufacturers Analysis

10.1 Pfizer

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Anti Obesity Drugs Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Merck

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Anti Obesity Drugs Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Roche

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Anti Obesity Drugs Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 GlaxoSmithKline

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Anti Obesity Drugs Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 AstraZeneca

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Anti Obesity Drugs Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Boehringer Ingelheim

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Anti Obesity Drugs Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Novo Nordisk

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Anti Obesity Drugs Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Eisai

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Anti Obesity Drugs Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Norgine

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Anti Obesity Drugs Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Arena Pharmaceuticals

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Anti Obesity Drugs Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Orexigen Therapeutics

10.12 Vivus

10.13 Alizyme

10.14 Rhythm Pharmaceuticals

10.15 Shionogi

10.16 Zafgan

11 Anti Obesity Drugs Manufacturing Cost Analysis

11.1 Anti Obesity Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Anti Obesity Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Anti Obesity Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Anti Obesity Drugs Market Forecast (2016-2021)

14.1 Germany Anti Obesity Drugs Sales Forecast (2016-2021)

14.2 France Anti Obesity Drugs Sales Forecast (2016-2021)

14.3 UK Anti Obesity Drugs Sales Forecast (2016-2021)

14.4 Russia Anti Obesity Drugs Sales Forecast (2016-2021)

14.5 Italy Anti Obesity Drugs Sales Forecast (2016-2021)

14.6 Spain Anti Obesity Drugs Sales Forecast (2016-2021)

14.7 Benelux Anti Obesity Drugs Sales Forecast (2016-2021)

14.8 Europe Anti Obesity Drugs Sales Forecast by Type (2016-2021)

14.9 Europe Anti Obesity Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Anti Obesity Drugs

Table Classification of Anti Obesity Drugs

Figure Europe Sales Market Share of Anti Obesity Drugs by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Anti Obesity Drugs

Figure Europe Sales Market Share of Anti Obesity Drugs by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure France Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure UK Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Anti Obesity Drugs Sales and Growth Rate (2011-2021)

Figure Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

Table Europe Anti Obesity Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Anti Obesity Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Anti Obesity Drugs Sales Share by Manufacturers

Figure 2016 Anti Obesity Drugs Sales Share by Manufacturers

Table Europe Anti Obesity Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Anti Obesity Drugs Revenue Share by Manufacturers

Table 2016 Europe Anti Obesity Drugs Revenue Share by Manufacturers

Table Europe Anti Obesity Drugs Sales and Market Share by Type (2011-2016)

Table Europe Anti Obesity Drugs Sales Share by Type (2011-2016)

Figure Sales Market Share of Anti Obesity Drugs by Type (2011-2016)

Figure Europe Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)

Table Europe Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)

Table Europe Anti Obesity Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Anti Obesity Drugs by Type (2011-2016)

Figure Europe Anti Obesity Drugs Revenue Growth Rate by Type (2011-2016)

Table Europe Anti Obesity Drugs Sales and Market Share by Countries (2011-2016)

Table Europe Anti Obesity Drugs Sales Share by Countries (2011-2016)

Figure Sales Market Share of Anti Obesity Drugs by Countries (2011-2016)

Table Europe Anti Obesity Drugs Revenue and Market Share by Countries (2011-2016)

Table Europe Anti Obesity Drugs Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Anti Obesity Drugs by Countries (2011-2016)

Table Europe Anti Obesity Drugs Sales and Market Share by Application (2011-2016)

Table Europe Anti Obesity Drugs Sales Share by Application (2011-2016)

Figure Sales Market Share of Anti Obesity Drugs by Application (2011-2016)

Figure Germany Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure Germany Anti Obesity Drugs Sales Price Trend (2011-2016)

Table Germany Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Anti Obesity Drugs Sales by Type (2015 and 2016)

Table Germany Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table Germany Anti Obesity Drugs Sales by Application (2015 and 2016)

Table Germany Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure France Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure France Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure France Anti Obesity Drugs Sales Price Trend (2011-2016)

Table France Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table France Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table France Anti Obesity Drugs Sales by Type (2015 and 2016)

Table France Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table France Anti Obesity Drugs Sales by Application (2015 and 2016)

Table France Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure UK Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure UK Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure UK Anti Obesity Drugs Sales Price Trend (2011-2016)

Table UK Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table UK Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Anti Obesity Drugs Sales by Type (2015 and 2016)

Table UK Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table UK Anti Obesity Drugs Sales by Application (2015 and 2016)

Table UK Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure Russia Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure Russia Anti Obesity Drugs Sales Price Trend (2011-2016)

Table Russia Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Anti Obesity Drugs Sales by Type (2015 and 2016)

Table Russia Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table Russia Anti Obesity Drugs Sales by Application (2015 and 2016)

Table Russia Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure Italy Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure Italy Anti Obesity Drugs Sales Price Trend (2011-2016)

Table Italy Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Anti Obesity Drugs Sales by Type (2015 and 2016)

Table Italy Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table Italy Anti Obesity Drugs Sales by Application (2015 and 2016)

Table Italy Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure Spain Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure Spain Anti Obesity Drugs Sales Price Trend (2011-2016)

Table Spain Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Anti Obesity Drugs Sales by Type (2015 and 2016)

Table Spain Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table Spain Anti Obesity Drugs Sales by Application (2015 and 2016)

Table Spain Anti Obesity Drugs Market Share by Application (2015 and 2016)

Figure Benelux Anti Obesity Drugs Sales and Growth Rate (2011-2016)

Figure Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2016)

Figure Benelux Anti Obesity Drugs Sales Price Trend (2011-2016)

Table Benelux Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Anti Obesity Drugs Sales by Type (2015 and 2016)

Table Benelux Anti Obesity Drugs Market Share by Type (2015 and 2016)

Table Benelux Anti Obesity Drugs Sales by Application (2015 and 2016)

Table Benelux Anti Obesity Drugs Market Share by Application (2015 and 2016)

Table Anti Obesity Drugs Basic Information List

Table Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Anti Obesity Drugs Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Anti Obesity Drugs Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Anti Obesity Drugs Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Anti Obesity Drugs Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Anti Obesity Drugs Sales Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim Anti Obesity Drugs Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Anti Obesity Drugs Sales Market Share (2011-2016)

Table Eisai Basic Information List

Table Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Anti Obesity Drugs Sales Market Share (2011-2016)

Table Norgine Basic Information List

Table Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Norgine Anti Obesity Drugs Sales Market Share (2011-2016)

Table Arena Pharmaceuticals Basic Information List

Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)

Table Orexigen Therapeutics Basic Information List

Table Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Orexigen Therapeutics Anti Obesity Drugs Sales Market Share (2011-2016)

Table Vivus Basic Information List

Table Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Vivus Anti Obesity Drugs Sales Market Share (2011-2016)

Table Alizyme Basic Information List

Table Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alizyme Anti Obesity Drugs Sales Market Share (2011-2016)

Table Rhythm Pharmaceuticals Basic Information List

Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)

Table Shionogi Basic Information List

Table Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shionogi Anti Obesity Drugs Sales Market Share (2011-2016)

Table Zafgan Basic Information List

Table Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zafgan Anti Obesity Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Anti Obesity Drugs

Figure Manufacturing Process Analysis of Anti Obesity Drugs

Figure Anti Obesity Drugs Industrial Chain Analysis

Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015

Table Major Buyers of Anti Obesity Drugs

Table Distributors/Traders List

Figure Germany Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Germany Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure France Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure France Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure UK Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure UK Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Russia Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Italy Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Spain Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Europe Anti Obesity Drugs Sales Forecast by Type (2016-2021)

Table Europe Anti Obesity Drugs Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370